Statutory Committee inquiries
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 23 October, Tuesday 24 October, Wednesday 25 October and Thursday 26 October 2006 to hear the following inquiries:
1. The committee will resume the inquiry into a complaint by the Council
of the Society against Bijal Vithalbhai Patel (registration number 84459)
and Greenoaks Pharmacy Ltd (identification number 1003087), which alleges
that the submission of wrong claims to the Prescription Pricing Authority
resulting in an overpayment to the company of £16,509.67; the operation
of a system involving the alteration of endorsements on prescriptions
by a superintendent pharmacist who was not the dispensing pharmacist
and without consultation with the dispensing pharmacist; a lack of professional
knowledge in relation to prescribing for and dispensing of the contraceptive
pill; the failure to keep knowledge up to date in relation to endorsements
and the Drug Tariff; the incorrect instruction by the superintendent
pharmacist to a dispensing pharmacist employed by the company in respect
of dispensing against prescriptions for the contraceptive pill; and the
dishonest and/or erroneous completion and/or submission of untrue declarations
contained in applications for inclusion on the primary care trust’s
list, individually or cumulatively may amount to misconduct.
2. The new inquiry into the case of Tanusha Jeena (registration number 1078315)
and Hiteshkumar Vanmalibhai Patel (registration number F567) which alleges
that the supply of the following against a prescription calling for (inter
alia) 84 allopurinol tablets 100mg: (a) a manufacturer’s box marked allopurinol
containing 32 allopurinol 100mg tablets, (being 28 tablets plus four additional
tablets in a cut blister foil bearing no batch number or expiry date) containing
no patient information leaflet and labelled as 28 allopurinol 100mg tablets;
(b) a white carton containing 24 atenolol 100mg tablets and a patient information
leaflet for allopurinol, labelled as 28 allopurinol 100mg tablets; and (c)
a manufacturer’s box marked atenolol containing 28 atenolol 100mg tablets
and a patient information leaflet for atenolol, labelled as 28 allopurinol
100mg tablets; and a failure to check that patients recently prescribed allopurinol
had received the correct prescribed medication following the discovery that
atenolol 100mg had been placed incorrectly on the shelf in the space where
allopurinol 100mg should have been, may amount to misconduct.
3. The new inquiry into a complaint by the Council of the Society against Owynn
Llewellyn Ronald Baker (registration number 87556) which alleges that the theft
of 72 dihydrocodeine tablets; taking without authority a patient-returned pack
of dihydrocodeine tablets; taking without the authority of a prescription a
quantity of amitryptiline tablets; the possession of a Class C drug contrary
to the Misuse of Drugs Act 1972; and the possession of two offensive weapons
contrary to the Prevention of Crime Act 1953, may amount to misconduct.
4. The committee will deliver the determination of the inquiry into a complaint
by the Council of the Society against Samuel Edwin Ashby (registration number
R6879), which alleged that a number of dispensing errors; unprofessional behaviour
towards members of staff, on occasion in the presence of customers; the removal
of patient returned medicines for his own use; the use of medicines not prescribed
for him; a failure to assist a patient appropriately; the use of aggressive
and offensive language towards an inspector and a pharmacist adviser of the
Royal Pharmaceutical Society; the dispensing of medicinal products otherwise
than in accordance with a prescription; a failure to read the Code of Ethics;
the physical assault of a member of staff and a failure to co-operate with
the Society’s investigation into the above incident, may amount to misconduct.
5. The committee will resume the inquiry into the case of Michael Murray (registration
number 67466), who was convicted of driving a motor vehicle after consuming
so much alcohol that the proportion of it in his breath exceeded the prescribed
limit, contrary to Section 5(1)(a) of the Road Traffic Act 1988 and Schedule
2 of the Road Traffic Offenders Act 1988.
6. The committee will resume the inquiry into the case of Gillian Case (formerly
Eldridge, registration number 68186), who was convicted of driving a motor
vehicle after consuming so much alcohol that the proportion of it in her breath
exceeded the prescribed limit, contrary to Section 5(1)(a) of the Road Traffic
Act 1988 and Schedule 2 of the Road Traffic Offenders Act 1988.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal